What's breaking now, across thousands of outlets.
(MedPage Today) -- Two Big Pharma companies have reportedly paused their ongoing trials of chimeric antigen receptor (CAR) T-cell therapies in lupus and other autoimmune inflammatory diseases after some participants suffered severe adverse events...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Readers respond to an article by Dr Zubir Ahmed, who argued that better palliative care should be prioritised before assisted dying is legalised I work as a renal physician, including on a transplant…
Readers respond to a report on the tragic consequences of the ‘care cliff’, when vital support is taken away at age 18 Your article draws attention to a landmark review that describes the “care cliff”…
Around 200,000 people in the Israeli-occupied West Bank will lose access to vital food aid from the United Nations World Food Programme (WFP) due to funding cuts, exacerbating food insecurity.
Here's a timeline of how federal public health officials went from offering Pennsylvanians their condolences to questioning whether the deaths occurred.
Here's a timeline of how federal public health officials went from offering Pennsylvanians their condolences to questioning whether the deaths occurred.
Based in Cambridge, MA, Merida develops biologic drugs that are engineered to selectively degrade pathogenic autoantibodies linked to a number of immune-mediated conditions.
